These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32891356)

  • 1. Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer.
    Ryu YJ; Yoon JH
    Surg Oncol; 2020 Sep; 34():67-73. PubMed ID: 32891356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
    Ryu YJ; Cho JS; Park MH; Yoon JH
    BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome.
    Jeong JS; Kim HK; Lee CR; Park S; Park JH; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
    J Korean Med Sci; 2012 Aug; 27(8):883-9. PubMed ID: 22876054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma.
    Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
    Endocr Relat Cancer; 2016 Jan; 23(1):27-34. PubMed ID: 26598713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.
    Ryu YJ; Cho JS; Yoon JH; Park MH
    World J Surg Oncol; 2018 Oct; 16(1):205. PubMed ID: 30314503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer.
    Lee I; Kim HK; Soh EY; Lee J
    World J Surg; 2020 May; 44(5):1506-1513. PubMed ID: 31915977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
    Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.
    Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
    Medicine (Baltimore); 2018 Dec; 97(51):e13435. PubMed ID: 30572443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
    Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
    Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
    Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of co-existent thyroiditis on clinical outcome in papillary thyroid carcinoma with high preoperative serum antithyroglobulin antibody: a retrospective cohort study.
    Nam HY; Lee HY; Park GC
    Clin Otolaryngol; 2016 Aug; 41(4):358-64. PubMed ID: 26283460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: The MASTER study.
    Heo DB; Won HR; Tae K; Kang YE; Jeon E; Ji YB; Chang JW; Choi JY; Yu HW; Ku EJ; Lee EK; Kim M; Choe JH; Koo BS;
    Surgery; 2024 Apr; 175(4):1049-1054. PubMed ID: 38281855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Lateral Neck Recurrence of N0/N1a Papillary Thyroid Cancer.
    Kim Y; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2017 Nov; 24(12):3609-3616. PubMed ID: 28822118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic lymph node dissection in papillary thyroid carcinoma: is there a place for lateral neck dissection?
    Ducoudray R; Trésallet C; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
    World J Surg; 2013 Jul; 37(7):1584-91. PubMed ID: 23564213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
    Jeon MJ; Yoon JH; Han JM; Yim JH; Hong SJ; Song DE; Ryu JS; Kim TY; Shong YK; Kim WB
    Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Chronic Lymphocytic Thyroiditis on Clinicopathologic Factors in Papillary Thyroid Cancer.
    Sakiz D; Sencar ME; Calapkulu M; Ozturk Unsal I; Aktas L; Ucan B; Ozbek M; Cakal E
    Endocr Pract; 2021 Dec; 27(12):1199-1204. PubMed ID: 34293511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
    Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
    Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of coexistent Hashimoto's thyroiditis on the extent of cervical lymph node dissection and prognosis in papillary thyroid carcinoma.
    Song E; Jeon MJ; Park S; Kim M; Oh HS; Song DE; Kim WG; Kim WB; Shong YK; Kim TY
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):123-128. PubMed ID: 28906015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of chronic lymphocytic thyroiditis in central node metastasis of papillary thyroid carcinoma.
    Paulson LM; Shindo ML; Schuff KG
    Otolaryngol Head Neck Surg; 2012 Sep; 147(3):444-9. PubMed ID: 22547555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma.
    Song E; Oh HS; Jeon MJ; Chung KW; Hong SJ; Ryu JS; Baek JH; Lee JH; Kim WG; Kim WB; Shong YK; Kim TY
    Int J Cancer; 2019 Mar; 144(6):1414-1420. PubMed ID: 30357831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.